Moderna (MRNA) Initiates Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273)
Go back to Moderna (MRNA) Initiates Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273)| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 183.74 +10.80 (6.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $172.94 | 52 Week High | $0.52 | |||
| Open | $168.50 | 52 Week Low | $0.08 | |||
| Day High | $187.20 | P/E | N/A | |||
| Day Low | $168.30 | EPS | $-3.80 | |||
| Volume | 13,961,970 | |||||
| Pre-Paid Legal Services, Inc. (NASDAQ: PPD) | Delayed: 47.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.30 | 52 Week High | $68.66 | |||
| Open | $47.30 | 52 Week Low | $44.05 | |||
| Day High | $47.30 | P/E | 7.11 | |||
| Day Low | $47.30 | EPS | $6.65 | |||
| Volume | 20,772 | |||||
